| Literature DB >> 10967578 |
T K Held1, S S Biel, A Nitsche, A Kurth, S Chen, H R Gelderblom, W Siegert.
Abstract
Hemorrhagic cystitis (HC) is a common complication following high-dose chemotherapy and bone marrow transplantation, and the treatment of virus-associated HC remains to be optimized. This is the first report on the successful use of cidofovir in a patient with HC and polyoma viruria concomitant with CMV reactivation after allogeneic BMT. Treatment led to a significant decrease in viruria and to sustained suppression of CMV reactivation. Administered with probenecid and hydration, cidofovir was well tolerated, and there were no side-effects.Entities:
Mesh：
Substances：
Year: 2000 PMID： 10967578 DOI： 10.1038/sj.bmt.1702487
Source DB: PubMed Journal: Bone Marrow Transplant ISSN： 0268-3369 Impact factor: 5.483